Skip Ribbon Commands
Skip to main content


Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO)nano.png
GECCO is an international collaboration that focuses on the identification and characterization of genetic risk factors for colorectal cancer (CRC). This cooperative effort involves researchers from North America, Australia, and Europe. To date, we have gathered data from approximately 40,000 participants from 36 different studies.
We aim to accelerate the discovery of CRC-related variants by replicating and characterizing genome-wide association study (GWAS) findings, and by conducting large-scale analyses of existing and newly generated GWAS data. Additionally, the consortium is investigating interactions between genetic variants and established epidemiologic risk factors for CRC.
We are able to study the impact of common and rare genetic variants across the entire genome by performing whole genome sequencing and genotyping. The large amount of data that GECCO has collected for CRC allows for investigation into survival and risk modeling as well. GECCO is now aiming to broaden its investigation of colorectal cancer risk by examining tumor characteristics in concert with host characteristics.

GECCO in the News : How inherited genes influence cancer immunity

"AACR 2017: Fuelling the 2nd Revolution in Cancer Research published by the Technology Network's Cancer Research Community

 GECCO 2017 Group photo.jpg
The Coordinating Center is located at the Fred Hutchinson Cancer Research Center in Seattle, Washington. For questions about GECCO please contact the principal investigator, Ulrike Peters :
Ulrike (Riki) Peters, PhD, MPH
Member, Fred Hutchinson Cancer Research Center
Research Professor, University of Washington
1100 Fairview Avenue N, M4-B402
Seattle, WA 98109-1024
Phone: (206) 667-2450